BIOMAT Database Logo BIOMAT Database Logo

Preparation and infusion of cryoprecipitate from exercised donors. 1973

C van Gastel, and J J Sixma, and E Borst-Eilers, and M Leautavd, and M Moes, and P M van der Plas, and B N Bouma, and J P Sybesma

UI MeSH Term Description Entries
D008297 Male Males
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D003080 Cold Temperature An absence of warmth or heat or a temperature notably below an accustomed norm. Cold,Cold Temperatures,Temperature, Cold,Temperatures, Cold
D005082 Physical Exertion Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included. Physical Effort,Effort, Physical,Efforts, Physical,Exertion, Physical,Exertions, Physical,Physical Efforts,Physical Exertions
D005167 Factor VII Heat- and storage-stable plasma protein that is activated by tissue thromboplastin to form factor VIIa in the extrinsic pathway of blood coagulation. The activated form then catalyzes the activation of factor X to factor Xa. Coagulation Factor VII,Proconvertin,Stable Factor,Blood Coagulation Factor VII,Factor 7,Factor Seven,Factor VII, Coagulation
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006467 Hemophilia A The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage. Factor VIII Deficiency,Hemophilia,Autosomal Hemophilia A,Classic Hemophilia,Deficiency, Factor VIII,Factor 8 Deficiency, Congenital,Factor VIII Deficiency, Congenital,Haemophilia,Hemophilia A, Congenital,Hemophilia, Classic,As, Autosomal Hemophilia,Autosomal Hemophilia As,Classic Hemophilias,Congenital Hemophilia A,Congenital Hemophilia As,Hemophilia A, Autosomal,Hemophilia As,Hemophilia As, Autosomal,Hemophilia As, Congenital,Hemophilias, Classic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

C van Gastel, and J J Sixma, and E Borst-Eilers, and M Leautavd, and M Moes, and P M van der Plas, and B N Bouma, and J P Sybesma
Production of high-potency cryoprecipitate from exercised blood donors and the treatment of hemophilia A with this material.
October 1974, American journal of clinical pathology,
C van Gastel, and J J Sixma, and E Borst-Eilers, and M Leautavd, and M Moes, and P M van der Plas, and B N Bouma, and J P Sybesma
Cryoprecipitate preparation.
January 1980, Transfusion,
C van Gastel, and J J Sixma, and E Borst-Eilers, and M Leautavd, and M Moes, and P M van der Plas, and B N Bouma, and J P Sybesma
Cryoprecipitate preparation.
October 1978, Lancet (London, England),
C van Gastel, and J J Sixma, and E Borst-Eilers, and M Leautavd, and M Moes, and P M van der Plas, and B N Bouma, and J P Sybesma
Cryoprecipitate preparation.
January 1979, Lancet (London, England),
C van Gastel, and J J Sixma, and E Borst-Eilers, and M Leautavd, and M Moes, and P M van der Plas, and B N Bouma, and J P Sybesma
Platelet and cryoprecipitate transfusions from female donors improve coagulopathy in vitro.
April 2023, The journal of trauma and acute care surgery,
C van Gastel, and J J Sixma, and E Borst-Eilers, and M Leautavd, and M Moes, and P M van der Plas, and B N Bouma, and J P Sybesma
Preparation of antihemophilic factor and fibronectin from human plasma cryoprecipitate.
January 1984, Transfusion,
C van Gastel, and J J Sixma, and E Borst-Eilers, and M Leautavd, and M Moes, and P M van der Plas, and B N Bouma, and J P Sybesma
Preparation of cryoprecipitate from riboflavin and UV light-treated plasma.
April 2012, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis,
C van Gastel, and J J Sixma, and E Borst-Eilers, and M Leautavd, and M Moes, and P M van der Plas, and B N Bouma, and J P Sybesma
The use of plasma from exercised donors in haemophilia. Preliminary report.
June 1967, Australian dental journal,
C van Gastel, and J J Sixma, and E Borst-Eilers, and M Leautavd, and M Moes, and P M van der Plas, and B N Bouma, and J P Sybesma
Plasma fibrinogen levels following cryoprecipitate infusion.
January 1970, Transfusion,
C van Gastel, and J J Sixma, and E Borst-Eilers, and M Leautavd, and M Moes, and P M van der Plas, and B N Bouma, and J P Sybesma
Inappropriate intravenous infusion set occluded by cryoprecipitate.
September 2022, Transfusion,
Copied contents to your clipboard!